SION (Sionna Therapeutics) Accounts Payable: $2.11 Mil (As of Mar. 2026)


SION Sionna Therapeutics Inc SION
12 GF Score
Price $43.99
! 3 Warning Signs
View Full Analysis

What is Sionna Therapeutics Accounts Payable?

Sionna Therapeutics SION +5.64% 12 Accounts Payable is $2.11 Mil as of Mar. 2026. GuruFocus rates SION with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Sionna Therapeutics's Accounts Payable for the quarter that ended in Mar. 2026 was $2.11 Mil.

Sionna Therapeutics's quarterly Accounts Payable declined from Sep. 2025 ($1.48 Mil) to Dec. 2025 ($0.77 Mil) but then increased from Dec. 2025 ($0.77 Mil) to Mar. 2026 ($2.11 Mil).

Sionna Therapeutics's annual Accounts Payable increased from Dec. 2023 ($0.72 Mil) to Dec. 2024 ($1.19 Mil) but then declined from Dec. 2024 ($1.19 Mil) to Dec. 2025 ($0.77 Mil).

Sionna Therapeutics Accounts Payable Related Terms

Sionna Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Sionna Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sionna Therapeutics Accounts Payable Chart

Sionna Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Accounts Payable
0.56 0.72 1.19 0.77

Sionna Therapeutics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.02 0.91 1.48 0.77 2.11
SION
12GF Score
Sionna Therapeutics Inc SION
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sionna Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $2.11 Mil mean?
Sionna Therapeutics (SION) has a Accounts Payable of $2.11 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Sionna Therapeutics and its competitors.
Is Sionna Therapeutics' Accounts Payable too high?
Sionna Therapeutics' current Accounts Payable is $2.11 Mil. Overall, Sionna Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Sionna Therapeutics' Accounts Payable compare to TYRA and RAPP?
Sionna Therapeutics' Accounts Payable of $2.11 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Sionna Therapeutics and its competitors. Sionna Therapeutics's current Accounts Payable is $2.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sionna Therapeutics stock overvalued right now?
Sionna Therapeutics (SION) has a current Accounts Payable of $2.11 Mil. The current Accounts Payable is $2.11 Mil. Sionna Therapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Sionna Therapeutics (SION), the current Accounts Payable is $2.11 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sionna Therapeutics Business Description

Address 21 Hickory Drive, Suite 500, Waltham, MA, USA, 02451
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
12GF Score

Get the complete analysis for SION

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.99
Price